Christoph U. Correll

Research interests

Publications

• Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

  Molecular Psychiatry · 2023 · https://doi.org/10.1038/s41380-023-02138-4

• Towards a youth mental health paradigm: a perspective and roadmap

  Molecular Psychiatry · 2023 · https://doi.org/10.1038/s41380-023-02202-z

• Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends

  Neuroscience & Biobehavioral Reviews · 2022 · https://doi.org/10.1016/j.neubiorev.2022.104608

• Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

  World Psychiatry · 2022 · https://doi.org/10.1002/wps.20994

• Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries

  Molecular Psychiatry · 2022 · https://doi.org/10.1038/s41380-022-01630-7

• Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies

  Molecular Psychiatry · 2021 · https://doi.org/10.1038/s41380-021-01161-7

• Preventive psychiatry: a blueprint for improving the mental health of young people

  World Psychiatry · 2021 · https://doi.org/10.1002/wps.20869

• How mental health care should change as a consequence of the COVID-19 pandemic

  The Lancet Psychiatry · 2020 · https://doi.org/10.1016/s2215-0366(20)30307-2

• 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)

  World Psychiatry · 2020 · https://doi.org/10.1002/wps.20699

• Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia

  JAMA Psychiatry · 2019 · https://doi.org/10.1001/jamapsychiatry.2018.4320

• Association of Antidepressant Use With Adverse Health Outcomes

  JAMA Psychiatry · 2019 · https://doi.org/10.1001/jamapsychiatry.2019.2859

• Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people

  The Lancet Psychiatry · 2019 · https://doi.org/10.1016/s2215-0366(19)30414-6

• The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

  The Lancet Psychiatry · 2019 · https://doi.org/10.1016/s2215-0366(19)30132-4

• Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis

  JAMA Psychiatry · 2018 · https://doi.org/10.1001/jamapsychiatry.2018.0623

• Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis

  Schizophrenia Bulletin · 2016 · https://doi.org/10.1093/schbul/sbw058

• Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

  American Journal of Psychiatry · 2016 · https://doi.org/10.1176/appi.ajp.2016.16050503

• Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

  American Journal of Psychiatry · 2015 · https://doi.org/10.1176/appi.ajp.2015.14101329

• Inverse relationship between body mass index and mortality in older nursing home residents: a meta‐analysis of 19,538 elderly subjects

  Obesity Reviews · 2015 · https://doi.org/10.1111/obr.12309

• Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder

  CNS Drugs · 2012 · https://doi.org/10.2165/11634500-000000000-00000

• Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

  The British Journal of Psychiatry · 2011 · https://doi.org/10.1192/bjp.bp.110.084665

• Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

  Nature Reviews Endocrinology · 2011 · https://doi.org/10.1038/nrendo.2011.156

• Summary of Product Characteristics

  Journal · 2010 · https://doi.org/10.1007/978-3-540-68706-1_698

• Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns

  European Neuropsychopharmacology · 2009 · https://doi.org/10.1016/j.euroneuro.2009.04.008

• Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials

  American Journal of Psychiatry · 2003 · https://doi.org/10.1176/appi.ajp.160.7.1209

Current projects

No projects listed.